[Detection of Australia antigen by radioimmunoassay during a course of viral hepatitis]. 1975

G Federico, and E Pizzigallo, and G Camilli

The AA. carried out the research of Australia Antigen by radioimmunoassay (RIA) as well as with counter-electrophoresis technique (CE) on 142 patients with acute viral hepatitis. For comparison the RIA determination of the Australia Antigen was also performed on 26 blood donors, already established Au positive by a preliminary screening with CE method. On the 142 patients examined, the RIA permitted the detection of 19 as Au positive above the number evidenced by the less-sensitive CE technique. The Au antigen levels, determined quantitatively in conventional units (c.u./0,1 ml of serum), continually decreased with the progress of the disease toward recovery. Yet, in 23 cases (44,3%), the antigen was still present in the serum after normalization of transaminases. The AA. call attention to the importance the Au positive hepatitis convalescents and Au positive blood donors could have in the transmission of the disease. The antigen levels of blood donors, when determined with RIA, were found comparable to those observed in the acute phase of viral hepatitis.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

G Federico, and E Pizzigallo, and G Camilli
November 1975, Journal of immunology (Baltimore, Md. : 1950),
G Federico, and E Pizzigallo, and G Camilli
May 1971, Proceedings of the National Academy of Sciences of the United States of America,
G Federico, and E Pizzigallo, and G Camilli
June 1975, Quaderni Sclavo di diagnostica clinica e di laboratorio,
G Federico, and E Pizzigallo, and G Camilli
January 1974, Archives roumaines de pathologie experimentales et de microbiologie,
G Federico, and E Pizzigallo, and G Camilli
September 1970, The Indian journal of medical research,
G Federico, and E Pizzigallo, and G Camilli
April 1974, Wiadomosci lekarskie (Warsaw, Poland : 1960),
G Federico, and E Pizzigallo, and G Camilli
February 1972, California medicine,
G Federico, and E Pizzigallo, and G Camilli
May 1971, The Journal of pediatrics,
G Federico, and E Pizzigallo, and G Camilli
January 1971, Przeglad epidemiologiczny,
G Federico, and E Pizzigallo, and G Camilli
December 1969, Revue francaise d'etudes cliniques et biologiques,
Copied contents to your clipboard!